BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Mergers and Acquisitions

WuXi Biologics to Divest Leverkusen Plant to Terumo for €150M, Refocuses on Global DP Expansion

WuXi Biologics (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced that it has entered into ...

May 15, 2025 | News

GSK Acquires Efimosfermin from Boston Pharmaceuticals in $2 Billion Deal to Advance Liver Disease Pipeline

Affecting up to 5% of the global population, SLD represents an area of significant unmet medical need with limited treatment options Phase II data show ...

May 15, 2025 | News

QIAGEN Acquires Genoox to Boost AI-Driven Genomic Interpretation for Clinical Labs Globally

Acquisition adds Franklin solution, an AI-powered cloud platform for clinical decision support in genetic diseases Strengthens QIAGEN Digital Insights...

May 13, 2025 | News

Waters Integrates MALS into Empower™ Software to Accelerate Biologics QC and Slash Validation Time

Saves up to six months on compliant software validation in biopharmaceutical quality control. Reduces analysis time for biotherapeutic peptides and prot...

May 07, 2025 | News

PCI Pharma Services Acquires Ajinomoto Althea’s Altair to Build Global Powerhouse in Aseptic Filling and Advanced Drug Delivery

PCI Pharma Services ("PCI") is pleased to announce the launch of Ajinomoto Althea, the world's leading contract research and manufacturing organi...

May 05, 2025 | News

Merck to Acquire SpringWorks Therapeutics for $3.9 Billion, Strengthening Rare Tumor Leadership

Purchase price of $47 per share in cash represents an enterprise value of €3.0 billion ($3.4 billion), or an equity value of approximately $3.9 bill...

April 28, 2025 | News

Suvoda and Greenphire Merge to Create Unified Platform for Streamlining Clinical Trials

Suvoda, a global clinical trial technology company specializing in randomization and trial supply management, consent, and patient outcomes data collection...

April 25, 2025 | News

Norgine to Acquire Theravia, Strengthening Its Rare Disease Portfolio Across Europe

Norgine and Theravia announced that they have entered into a definitive agreement under which Norgine will acquire Theravia, an international pharmace...

April 17, 2025 | News

Rege Nephro Acquires Tamibarotene Assets from Syros Pharmaceuticals to Advance ADPKD Program

Rege Nephro Co., Ltd. (Headquarter: Kyoto, Japan; Chief Executive Officer: Akifumi Morinaka) has announced that it has successfully acquired Tami...

April 16, 2025 | News

Turn Bio Acquires ARMMs Technology to Advance Precision Epigenetic Therapies Across More Tissues and Indications

ARMMs brings precision medicine through targeted, non-viral vesicular delivery Synergy of ARMMs and eTurna™ LNP platforms means company can delive...

March 27, 2025 | News

Azurity Pharmaceuticals Completes Acquisition of Covis Group, Expanding Global Footprint and Therapeutic Portfolio

Azurity Pharmaceuticals ("Azurity") announced the successful completion of its acquisition of Covis Group S.à r.l. ("Covis") from e...

March 17, 2025 | News

MasterControl Acquires Qualer to Integrate Asset Management into Life Sciences Quality and Manufacturing Platform

MasterControl, a leading provider of quality and manufacturing software solutions for life sciences, announced the acquisition of Qualer, a cloud-native as...

March 04, 2025 | News

WuXi XDC Expands Partnership with LigaChem to Accelerate Next-Gen ADC Development

WuXi XDC Cayman Inc. ("WuXi XDC", or the "Company", stock code: 2268.HK), a leading global CRDMO (Contract Research, Development, and Manufacturing Organiz...

February 26, 2025 | News

Thermo Fisher Scientific to Acquire Solventum’s Purification & Filtration Business for $4.1 Billion in Cash

Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”), the world leader in serving science, announced that the company has en...

February 25, 2025 | News

Stay Connected